venBio Partners LLC
SAN FRANCISCO, CA · CIK 1776382 · 13F filing filed 2026-08-14
Exempt reporting adviser since 2017 · limited liability company
- Private funds5 · $1.8bn gross assets
- Websitevenbio.com
- Form ADV · 2026-03-12SEC adviser record
- Kindventure, futures
- Others nearbySan Francisco, CA
As an employer
- Offices in1 country
- Private fundsventure capital 5
$519.4m
reported value
+85.1% vs Q1 2026
7positions
100.0%in top 10
2 new
1 added
1 reduced
1 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| PHARVARIS N V PHVS | $160.6m30.92% | Added +4.1k |
| PARABILIS MEDICINES INC PBLS | $144.1m27.75% | New |
| ALUMIS INC ALMS | $127.4m24.53% | Unchanged |
| ACHIEVE LIFE SCIENCES INC ACHV | $38.6m7.44% | New |
| ALX ONCOLOGY HLDGS INC ALXO | $26.7m5.14% | Unchanged |
| HARMONY BIOSCIENCES HLDGS IN HRMY | $17.2m3.31% | Reduced -17.0k |
| LYELL IMMUNOPHARMA INC LYEL | $4.7m0.91% | Unchanged |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| ARTIVA BIOTHERAPEUTICS INC ARTV | $3.4m531.3k shares |